1. Home
  2. WVE vs VERA Comparison

WVE vs VERA Comparison

Compare WVE & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$6.19

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$34.48

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WVE
VERA
Founded
2012
2016
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.5B
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
WVE
VERA
Price
$6.19
$34.48
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
16
10
Target Price
$29.81
$81.30
AVG Volume (30 Days)
3.9M
940.0K
Earning Date
04-28-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,704,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$85.67
$472.48
P/E Ratio
N/A
N/A
Revenue Growth
149.43
N/A
52 Week Low
$5.02
$19.07
52 Week High
$21.73
$56.05

Technical Indicators

Market Signals
Indicator
WVE
VERA
Relative Strength Index (RSI) 35.45 43.13
Support Level $6.02 $33.43
Resistance Level $7.65 $42.77
Average True Range (ATR) 0.35 1.84
MACD 0.05 0.11
Stochastic Oscillator 15.04 26.73

Price Performance

Historical Comparison
WVE
VERA

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: